SEAN BAYER: Open Payments
NPI 1992495113 · APPLE VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,574 in 131 payments from 12 companies in 2025. Trend: 2023 $255 · 2024 $1,493 · 2025 $2,574
Food & beverage: $2,565Education: $9
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 31 | $635 |
| Otsuka America Pharmaceutical, Inc. | 17 | $370 |
| ABBVIE INC. | 22 | $315 |
| Teva Pharmaceuticals USA, Inc. | 13 | $263 |
| Alkermes, Inc. | 13 | $241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $197 |
| Neurocrine BioSciences, Inc. | 7 | $171 |
| Supernus Pharmaceuticals, Inc. | 11 | $130 |
| Janssen Pharmaceuticals, Inc | 5 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
Products named: COBENFY, VRAYLAR, REXULTI, ARISTADA, CAPLYTA, INGREZZA, AUSTEDO XR, Qelbree.
Industry payments across CA — which companies pay providers there.
